Seebri Breezhaler 44 micrograms inhalation powder

DRUG2 trials

Sponsors

Hospices Civils De Lyon, Fundacio Privada Mon Clinic Barcelona

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Phase 4

Symptoms control and adhErenCe assessment during treatment with mepolizUmab new pREfilled devices. SECURE

CompletedCTIS2022-501029-19-00

Hospices Civils De LyonAsthma

Start: 2022-12-13End: 2025-03-27Target: 130Updated: 2024-01-15

THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICAL CONTROL IN HIGH-RISK GOLD B PATIENTS (B+)

CompletedCTIS2023-507304-32-00

Fundacio Privada Mon Clinic BarcelonaChronic Obstructive Pulmonary Disease

Start: 2024-02-09End: 2025-01-23Target: 1028Updated: 2024-04-04